Review of Psychopathology: Contemporary Jungian perspectives.

Reviews the book, Psychopathology: Contemporary Jungian perspectives edited by Andrew Samuels (see record 1991-97962-000). This book is a collection of relevant articles culled by the editor from the Journal of Analytical Psychology. Because the editor has collected what was available rather than having commissioned items specifically to span the topic for the book, the coverage of the range of psychopathology is spotty, although the major topics of depression, anxiety, psychosis, and personality disorders are covered. Several articles on narcissism are included as are also articles dealing with marital pathology and Holocaust victims. Most are from the perspective of Jungian therapy with the only other theoretical input used coming from self psychology. No other approaches are mentioned. Obviously, the book is likely to be a useful compendium to Jungian analysts. It is somewhat difficult to see how it could be useful to practitioners of other points of view. The language is replete with Jungian terms that are not explained and may not be immediately understandable for persons outside that system. There are two additional major flaws that are also apparent: The tone and language are decidedly British and refer to how the British mental health system is organized, which is, of course, somewhat different than ours; also, because of the publication dates, many of the articles have a dated quality. Both of these factors limit the potential audience for this book. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

The role of the family in the development of psychopathology.

Psychologists generally make the assumption that the experiences to which the individual is exposed over a period of time lead to the development of learned patterns of behavior. From this, psychologists have reasoned that the experiences the individual has in his early life at home, with his family, in general, and his mother, in particular, are major determinants in the learning of the constellation of behaviors subsumed under the rubric, personality, and in particular, the development of psychopathology. A review of the research of the past 40 yr. failed to support this assumption. No factors were found in the parent-child interaction of schizophrenics, neurotics, or those with behavior disorders which could be identified as unique to them or which could distinguish one group from the other, or any of the groups from the families of the controls. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Review of The Psychopathology of Women.

Reviews the book, The Psychopathology of Women by Ihsan Al-Issa (1980). The Psychopathology of Women, is a comprehensive examination of how Western culture influences the experience, expression and treatment of psychopathology in men and women. The chapters examine the major DSM - III categories in light of Dr. Al-Issa's premise that the diagnosis, experience and treatment of mental illness are related to sex roles. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Overview of the drug approval process.

Reviewed a database sponsored by the National Institutes of Health (NIH) that lists all clinical trials currently underway indicated that there are at least 400 investigational drugs in various stages of development for central nervous system (CNS) disorders, such as major depression, schizophrenia, Alzheimer's disease, and social anxiety disorder (NIH, 2002). Of the 65 new drugs approved in 2001, 10 were drugs for (CNS indications (S. Briggs et al., 2002). Given this level of activity, psychologists might benefit from an overview of the drug development process that would further their understanding of the dynamics involved in bringing a drug into the market. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Review of Handbook of clinical psychopharmacology for therapists.

Reviews the book, Handbook of clinical psychopharmacology for therapists by J. Preston, J. H. O'Neal, and M. C. Talaga (1994). This text is an extremely well-written, carefully organized, and practical volume that is entirely suitable for its stated purpose. The authors comment in their Introduction that their book is "intended primarily for mental health professionals and those in graduate training in psychology, social work, and counseling (p. 3)." The Handbook is organized around the DSM-IV and the attendant conception of mental disorders as having either an explicit or implicit biological basis. The authors do a sound job of specifying typical treatment regimens among the psychotropics, and they also cover the many marginal clinical circumstances which justify moving away from conventional treatment plans. The text is especially strong in addressing some augmentation strategies for treatment refractory mood disorders, the newer or "atypical" anti-psychotics, and utilization of the very flexible and utilitarian Selective Serotonin Re-uptake Inhibitors (SSRI's), such as fluoxetine (Prozac). This volume is especially recommended to two groups of users. The first are graduate-level instructors who are seeking a broad-based, informative, and practical text to introduce students to the burgeoning field of psychopharmacology. The second group of utilizers should be practicing clinicians, who need either to review or to update basic concepts in psychopharmacology as they interface with patients on a daily basis. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Implicit measures of association in psychopathology research.

Studies obtaining implicit measures of associations in Diagnostic and Statistical Manual of Mental Disorders (4th ed., Text Revision; American Psychiatric Association, 2000) Axis I psychopathology are organized into three categories: (a) studies comparing groups having a disorder with controls, (b) experimental validity studies, and (c) incremental and predictive validity studies. In the first category, implicit measures of disorder-relevant associations were consistent with explicit beliefs for some disorders (e.g., specific phobia), but for other disorders evidence was either mixed (e.g., panic disorder) or inconsistent with explicit beliefs (e.g., pain disorder). For substance use disorders and overeating, expected positive and unexpected negative associations with craved substances were found consistently. Contrary to expectation, implicit measures of self-esteem were consistently positive for patients with depressive disorder, social phobia, and body dysmorphic disorder. In the second category, short-term manipulations of disorder-relevant states generally affected implicit measures as expected. Therapeutic interventions affected implicit measures for one type of specific phobia, social phobia, and panic disorder, but not for alcohol use disorders or obesity. In the third category, implicit measures had predictive value for certain psychopathological behaviors, sometimes moderated by the availability of cognitive resources (e.g., for alcohol and food, only when cognitive resources were limited). The strengths of implicit measures include (a) converging evidence for dysfunctional beliefs regarding certain disorders and consistent new insights for other disorders and (b) prediction of some psychopathological behaviors that explicit measures cannot explain. Weaknesses include (a) that findings were inconsistent for some disorders, raising doubts about the validity of the measures, and (b) that understanding of the concept “implicit” is incomplete. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Psychopathology as a predictor of adolescent drug use trajectories.

The authors examined early psychopathology as a predictor of trajectories of drug use from ages 13-18 years. Six years of annual data were analyzed for 506 boys using a mixed effects polynomial growth curve model. They tested whether distinct measures of psychopathology and behavioral problems (i.e., attention-deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder, depression, and violence) assessed in early adolescence could prospectively predict level and change in alcohol and marijuana use. Higher levels of all of the types of psychopathology predicted higher levels of alcohol use, and higher levels of attention-deficit/hyperactivity disorder, conduct disorder, and violence predicted higher levels of marijuana use. Only conduct disorder predicted linear growth in alcohol use, and none of the measures predicted growth in marijuana use. The results suggest that drug use prevention programs should target youths with early symptoms of psychopathology. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Pediatric Psychopharmacology for Prepubertal Internalizing Disorders.

Evidence-based studies of drug, psychosocial and combined treatments for prepubertal internalizing disorders (depression, obsessive-compulsive disorder [OCD], and non-OCD anxiety) were reviewed. No age effects were found. Although no combined studies met evidence-based criteria, efficacious and possibly efficacious psychosocial and pharmacological treatments were identified, along with safety concerns for drug treatments. Evidentiary support favored psychosocial treatment for non-OCD anxiety disorders and pharmacological treatments for OCD, with mixed results for depression. Cost-benefit considerations suggest psychosocial treatments should be considered the first choice for at least anxiety and depression, except in unusual cases where stabilization may require pharmacological intervention first. (PsycINFO Database Record (c) 2011 APA, all rights reserved)     

Mental Illness and/or Mental Health? Investigating Axioms of the Complete State Model of Health.

A continuous assessment and a categorical diagnosis of the presence (i.e., flourishing) and the absence (i.e., languishing) of mental health were proposed and applied to the Midlife in the United States study data, a nationally representative sample of adults between the ages of 25 and 74 years (N = 3,032). Confirmatory factor analyses supported the hypothesis that measures of mental health (i.e., emotional, psychological, and social well-being) and mental illness (i.e., major depressive episode, generalized anxiety, panic disorder, and alcohol dependence) constitute separate correlated unipolar dimensions. The categorical diagnosis yielded an estimate of 18.0% flourishing and, when cross-tabulated with the mental disorders, an estimate of 16.6% with complete mental health. Completely mentally healthy adults reported the fewest health limitations of activities of daily living, the fewest missed days of work, the fewest half-day work cutbacks, and the healthiest psychosocial functioning (low helplessness, clear life goals, high resilience, and high intimacy). (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Pediatric psychopharmacology: A review of new developments and recent research.

Advances in psychopharmacology have revolutionalized the management of emotional and behavioral disorders in children and adolescents. Recent developments in pediatric psychopharmacology and the prevalence of pharmacotherapy for various psychological disorders in children are examined, and clinical updates for classes of psychotropics are provided. Issues including monitoring and assessing drug effects, acceptability and satisfaction, and the social, political, and cultural issues surrounding the use of psychotropics in children are discussed. The authors conclude that the current clinical use of psychotropics in children exceeds extant efficacy and safety data. The involvement of practicing psychologists in pediatric psychopharmacology and the need for a firm empirical foundation for pediatric psychopharmacology are also discussed. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Supporting and treating families with children on the autistic spectrum: The unique role of the generalist psychologist.

Research findings indicate that intensive behavior therapy (e.g., applied behavioral analysis, or ABA) represents an effective treatment for autistic spectrum disorders. Unfortunately, children with autism represent an underserved patient population. Parents often make treatment decisions with insufficient information and report problems in establishing and maintaining treatment programs. This practice review asserts that psychologists, including those without professional certification or coursework in ABA, are in a unique position to assist affected children and their families. Psychologists can provide critical information about evidence-based treatment; offer assistance in overcoming barriers to intensive treatment, including personnel selection; and provide ongoing support to family members. Case examples also illustrate how psychologists can help families address specific barriers to intensive treatment. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Psychopharmacology of aggression in children and adolescents with primary neuropsychiatric disorders: A review of current and potentially promising treatment options.

Research examining the role of pharmacological therapy in the treatment of children and adolescents with clinical disorders is growing. Clinical disorders that present with comorbid aggression can add a challenge to treatment. Child and adolescent neuropsychiatric disorders associated with aggression include attention-deficit hyperactivity disorder, various mood disorders and in particular bipolar disorders/pediatric mania, schizophrenia, mental retardation, oppositional defiant disorder, conduct disorder, and autism spectrum disorders. This review describes the psychopharmacy to treat these disorders and the aggression that often appears comorbidly. Existing literature regarding the efficacy and safety of psychotropics for youth with neuropsychiatric disorders also is discussed. In addition, general guidelines for psychopharmacy of aggression in children and adolescents are presented. Studies reviewed in this article provide evidence for the use of psychostimulants, alpha-2 agonists, beta blockers, lithium, anticonvulsant mood-stabilizers, atypical antipsychotics, traditional antipsychotics, and selective serotonin reuptake inhibitors in treating pediatric aggression with the choice of medication dependent on symptomology. Despite increased support for pediatric psychotropic use, there is a need for more long-term safety and efficacy studies of existing medications and newer, safer, and more effective agents with fewer side effects for the pharmacological treatment of all childhood disorders in which aggression is prominent. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

The Future of Mental Health.

Examines the two sets of criteria that generally categorize mental health: those that emphasize internal events and those that deal with external events. The author discusses the future of mental health in light of many of its current trends, including greater acceptance of diversity, and he discusses the potential future role of the mental health professional. The author notes that greater numbers of mental health professionals have gotten involved with different populations, and suggests that the majority of mental health professionals will probably be experts in handling small units of behavior or experience for a limited time. The very process of making predictions changes the future course of events. Let us hope that this intricate process will result in greater satisfaction for greater numbers of people. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Building the infrastructure: The effects of role identification behaviors on team cognition development and performance.

The primary purpose of this study was to extend theory and research regarding the emergence of mental models and transactive memory in teams. Utilizing Kozlowski, Gully, Nason, and Smith’s (1999) model of team compilation, we examined the effect of role identification behaviors and posited that such behaviors represent the initial building blocks of team cognition during the role compilation phase of team development. We then hypothesized that team mental models and transactive memory would convey the effects of these behaviors onto team performance in the team compilation phase of development. Results from 60 teams working on a command-and-control simulation supported our hypotheses. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

The direct and interactive effects of neuroticism and life stress on the severity and longitudinal course of depressive symptoms.

The direct and interactive effects of neuroticism and stressful life events (chronic and episodic stressors) on the severity and temporal course of depression symptoms were examined in 826 outpatients with mood and anxiety disorders, assessed on 3 occasions over a 1-year period (intake and 6- and 12-month follow-ups). Neuroticism, chronic stress, and episodic stress were uniquely associated with intake depression symptom severity. A significant interaction effect indicated that the strength of the effect of neuroticism on initial depression severity increased as chronic stress increased. Although neuroticism did not have a significant direct effect on the temporal course of depression symptoms, chronic stress significantly moderated this relationship such that neuroticism had an increasingly deleterious effect on depression symptom improvement as the level of chronic stress over follow-up increased. In addition, chronic stress (but not episodic stress) over follow-up was uniquely predictive of less depression symptom improvement. Consistent with a stress generation framework, however, initial depression symptom severity was positively associated with chronic stress during follow-up. The results are discussed in regard to diathesis–stress conceptual models of emotional disorders and the various roles of stressful life events in the onset, severity, and maintenance of depressive psychopathology. (PsycINFO Database Record (c) 2011 APA, all rights reserved)     

Characteristics of women working as child aides in a school-based preventive mental health program.

Investigated whether a group of 50 adult women hired to work as nonprofessional mental health workers (child aides) were higher than 40 demographically comparable controls on attributes which, on an a priori basis, could be expected to be related positively to effective functioning in their role. Ss were compared on the Personality Research Form, the SVIB, the Marlowe-Crowne Social Desirability scale, a semantic differential, the Situational Response Test, and R. Hogan's Empathy Scale. The groups were significantly differentiated from one another on a wide range of scales. The inference is drawn that the aide group possessed more desirable attributes than the control group for the role of nonprofessional mental health worker. (25 ref.) (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Presenting the Complex Client in Court: Practical Issues Related to the Assessment of Capacity.

This article discusses the complex client in guardianship proceedings with 2 case examples. Topics addressed include the role of the psychologist in court, options for the client (limited vs. full guardianship), and the type of information sought by attorneys and judges in these cases. In Case 1, Mrs. G., a woman with a long history of bipolar disorder and an emergent vascular dementia, is threatened with eviction because of fire starting. In Case 2, the family of Mr. J. is pressing for guardianship secondary to a history of substance abuse and poor medication compliance for HIV. In both cases, traits previously deemed eccentric by family members have become threats to safety. Fluctuation of cognitive functioning and the importance of medication compliance add to the complexity of these cases. (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Review of Childhood mental health disorders: Evidence base and contextual factors for psychosocial, psychopharmacological, and combined interventions.

Reviews the book, Childhood mental health disorders: Evidence base and contextual factors for psychosocial, psychopharmacological, and combined interventions by Ronald T. Brown, David O. Antonuccio, George J. Dupaul, Mary A. Fristad, Cheryl A. King, Laurel K. Leslie, Gabriele S. McCormick, William E. Pelham Jr., John C. Piacentini, and Benedetto Vitiello (see record 2007-15067-000). This volume stands as a significant contribution to the current state of affairs in child and adolescent mental health. Unassuming in size (a total of 207 pages including references and author and subject indexes), this compilation is not only of value to researchers and clinicians within the professions of psychology and psychiatry but holds significance across other professions (e.g., social work, occupational therapy, nursing) that serve and support the mental health care of children. This book consists of 13 chapters, of which 11 address common child and adolescent mental health disorders. The authors offer readers a concise summary of the status of support for psychosocial, pharmacological, and combined interventions balanced in the context of safety and potential harm. Recommendations are offered on the most appropriate first-line treatment for a particular disorder (which predominantly favours psychosocial interventions over psychoactive medications). This is a book that will be a significant resource for those seeking evidence-based guideposts to intervention with children, adolescents, and their families. It is a timely, accessible, well-organised text, giving fair consideration to pharmaceutical, psychosocial, and combined interventions. As the authors allude, this compilation represents a "snapshot in time" but sets forth a strong foundation for practise and an agenda to further clinical and research attention to children's mental health. (PsycINFO Database Record (c) 2010 APA, all rights reserved)